Christopher H. Boshoff
#158,985
Most Influential Person Now
Christopher H. Boshoff's AcademicInfluence.com Rankings
Christopher H. Boshoffmedical Degrees
Medical
#3160
World Rank
#3615
Historical Rank
Oncology
#218
World Rank
#226
Historical Rank
Christopher H. Boshoffphilosophy Degrees
Philosophy
#9095
World Rank
#12601
Historical Rank
Logic
#6086
World Rank
#7568
Historical Rank
Download Badge
Medical Philosophy
Christopher H. Boshoff's Degrees
- Masters Medicine University of Cape Town
Why Is Christopher H. Boshoff Influential?
(Suggest an Edit or Addition)Christopher H. Boshoff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The biology and management of non-small cell lung cancer (2018) (2193)
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing (2013) (1663)
- Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV (1996) (956)
- Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma (1995) (894)
- Kaposi's sarcoma and its associated herpesvirus (2010) (727)
- Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells (1995) (717)
- Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. (1999) (717)
- Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen (1996) (653)
- HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. (2000) (632)
- The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells (2000) (521)
- Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. (1997) (494)
- Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas (2006) (487)
- Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma (2004) (473)
- Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays (2001) (397)
- High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. (2002) (388)
- KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway (1997) (373)
- Cyclin encoded by KS herpesvirus (1996) (361)
- miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator (2010) (346)
- Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. (2001) (340)
- Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer (2000) (338)
- Kaposi's sarcoma-associated herpesvirus. (1997) (310)
- The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1 (1997) (307)
- APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. (2014) (292)
- Aids-related malignancies (2002) (283)
- Antibodies against human herpesvirus 8 in black South African patients with cancer. (1999) (272)
- Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. (1998) (265)
- Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment (2015) (264)
- Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production (2007) (256)
- Recurrent PTPRB and PLCG1 mutations in angiosarcoma (2014) (238)
- KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. (2000) (225)
- Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. (1998) (224)
- KSHV vFLIP binds to IKK-γ to activate IKK (2003) (222)
- Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. (1996) (214)
- K15 Protein of Kaposi’s Sarcoma-Associated Herpesvirus Is Latently Expressed and Binds to HAX-1, a Protein with Antiapoptotic Function (2002) (206)
- Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile (2003) (203)
- Predicting biomarkers for ovarian cancer using gene-expression microarrays (2004) (199)
- Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors (2013) (195)
- Degradation of p27Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin–cdk6 complex (1999) (189)
- Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. (2005) (185)
- Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. (1998) (178)
- Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. (1999) (177)
- Characterization of an anti‐apoptotic glycoprotein encoded by Kaposi's sarcoma‐associated herpesvirus which resembles a spliced variant of human survivin (2002) (176)
- Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa (1999) (173)
- Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. (2001) (170)
- The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. (2012) (165)
- KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. (2010) (164)
- Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. (1997) (162)
- First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial (2012) (158)
- The molecular pathology of Kaposi's sarcoma-associated herpesvirus. (2002) (145)
- Associations between Burkitt Lymphoma among Children in Malawi and Infection with HIV, EBV and Malaria: Results from a Case-Control Study (2008) (143)
- Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. (1999) (143)
- Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer (2011) (143)
- Toward personalized treatment approaches for non-small-cell lung cancer (2021) (141)
- KSHV vFLIP binds to IKK-gamma to activate IKK. (2003) (139)
- Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients (2009) (133)
- A molecular map of mesenchymal tumors (2005) (132)
- PROSPECTIVE STUDY OF THE EFFECTS OF ANTIRETROVIRAL THERAPY ON KAPOSI SARCOMA– ASSOCIATED HERPESVIRUS INFECTION IN PATIENTS WITH AND WITHOUT KAPOSI SARCOMA (2002) (126)
- Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. (2001) (123)
- Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma (2013) (119)
- Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. (2002) (117)
- KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. (2011) (117)
- Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. (2008) (117)
- Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia (2004) (114)
- Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. (2001) (112)
- Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. (2008) (109)
- Internal Ribosome Entry Site Regulates Translation of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein (2001) (109)
- Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy (2002) (107)
- Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. (2007) (107)
- Identification of Human Herpesvirus 8-Specific Cytotoxic T-Cell Responses (1999) (106)
- The epidemiology of conjunctival squamous cell carcinoma in Uganda (2002) (105)
- Secondary tumours following etoposide containing therapy for germ cell cancer. (1995) (105)
- KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. (2008) (100)
- Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells (2014) (99)
- HHV8 and skin cancers in immunosuppressed patients (1996) (94)
- Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6 (2005) (91)
- Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. (2006) (89)
- DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status (2010) (88)
- HIV infection and neoplasia (1996) (88)
- Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. (1999) (86)
- Characterization of Monoclonal Antibodies Raised against the Latent Nuclear Antigen of Human Herpesvirus 8 (1999) (85)
- Kidney cancer: The next decade (2018) (84)
- LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. (2004) (83)
- Complete response to erlotinib treatment in brain metastases from recurrent NSCLC (2005) (81)
- Understanding cancer (2006) (81)
- Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission (2000) (79)
- The sero‐epidemiology of Kaposi's sarcoma‐associated herpesvirus (KSHV/HHV‐8) in adults with cancer in Uganda (2003) (73)
- Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. (2007) (73)
- Increasing probability of mother-to-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8. (1999) (71)
- Risk factors for Kaposi's sarcoma: A case‐control study of HIV‐seronegative people in Uganda (2003) (71)
- KSHV Manipulates Notch Signaling by DLL4 and JAG1 to Alter Cell Cycle Genes in Lymphatic Endothelia (2009) (68)
- Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain (2001) (68)
- Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala (2005) (67)
- Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets (2009) (64)
- Human herpesvirus type 8 and Kaposi's sarcoma. (1998) (62)
- Multicenter Comparison of PCR Assays for Detection of Human Herpesvirus 8 DNA in Semen (1999) (62)
- Expression of FUS‐CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation (2013) (60)
- Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming. (2013) (60)
- Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes (2003) (54)
- Small-molecule mimics of an α-helix for efficient transport of proteins into cells (2007) (53)
- Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation (2006) (50)
- Cancer epigenome. (2010) (50)
- Viral coinfections among African children infected with human immunodeficiency virus type 1. (2003) (48)
- KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. (2006) (48)
- Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient. (2000) (46)
- Lentiviral manipulation of gene expression in human adult and embryonic stem cells. (2006) (45)
- A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein–Barr virus in adults with human immunodeficiency virus-1 (2006) (44)
- Kaposi's sarcoma: Coupling herpesvirus to angiogenesis (1998) (44)
- Gene expression array profile of human osteosarcoma (2003) (39)
- Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival (2014) (38)
- Distinct cellular origins of primary effusion lymphoma with and without EBV infection. (2004) (38)
- The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens (2009) (33)
- Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda (2003) (31)
- TOPICAL: Randomized phase III trial of erlotinib compared with placebo in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and unsuitable for first-line chemotherapy. (2010) (31)
- Integrated virus-host methylome analysis in head and neck squamous cell carcinoma (2013) (30)
- Aetiology of Kaposi's sarcoma: current understanding and implications for therapy. (1997) (30)
- Supplemental Data Crystal Structure of a vFlip-IKK γ Complex : Insights into Viral Activation of the IKK Signalosome (2008) (30)
- Small-molecule mimics of an alpha-helix for efficient transport of proteins into cells. (2007) (25)
- Etiology of AIDS-related Kaposi's sarcoma and lymphoma. (1997) (23)
- Characterisation of the anti-apoptotic function of survivin-ΔEx3 during TNFα−mediated cell death (2007) (23)
- Kaposi's Sarcoma‐Associated Herpesvirus: From Cell Biology to Pathogenesis (2000) (21)
- Adrenomedullin Haploinsufficiency Predisposes to Secondary Lymphedema (2013) (20)
- TAL‐1 protein expression in vascular lesions (1997) (20)
- Kaposi virus scores cancer coup (2003) (19)
- In vitro transformation of mesenchymal stem cells induces gradual genomic hypomethylation. (2010) (19)
- HHV8 AND SKIN CANCERS IN IMMUNOSUPPRESSED PATIENTS. AUTHORS' REPLY (1996) (18)
- The epidemiology of conjunctival squamous cell carcinoma in Uganda (2003) (18)
- Chondroblastomas but not chondromyxoid fibromas express cytokeratins: an unusual presentation of a chondroblastoma in the metaphyseal cortex of the tibia (2007) (18)
- Viral cyclins (2000) (17)
- Addressing controversies over Kaposi's sarcoma. (2000) (17)
- Endothelial cells and cancer. (2006) (17)
- Current Opinion: Hormone Replacement Therapy after a Diagnosis of Breast Cancer (1995) (15)
- Focal adhesion kinase is required for KSHV vGPCR signaling (2012) (13)
- HHV8 and skin cancers in immunosuppressed patients. (1996) (13)
- Kaposi sarcoma as a model of oncogenesis and cancer treatment (2007) (13)
- Kaposi's Sarcoma Biology (2002) (13)
- RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus (2003) (12)
- Exploring the Interaction Between siRNA and the SMoC Biomolecule Transporters: Implications for Small Molecule–Mediated Delivery of siRNA (2012) (12)
- Ephrin receptor: a door to KSHV infection (2012) (11)
- Linking Kaposi virus to cancer-associated cytokines. (2005) (11)
- Transforming activity of Fbxo 7 is mediated specifically through regulation of cyclin D / cdk 6 (2005) (11)
- Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. (1997) (10)
- Establishing a KSHV1 Cell Line (BCP-1) From Peripheral Blood and Characterizing Its Growth in Nod/SCID Mice (1998) (10)
- KSHV LANA inhibits TGF- (cid:1) signaling through epigenetic silencing of the TGF- (cid:1) type II receptor (2008) (9)
- Redefining KSHV latency. (2013) (9)
- Immunobiology and host response to KSHV infection. (2007) (9)
- Occurrence of human herpes virus 8 in Kaposi's sarcoma and other tumours in South Africa. (1997) (8)
- Topical: Randomized Phase III Trial of Erlotinib Compared with Placebo in Patients with Advanced Non–Small Cell Lung Cancer (NSCLC) Unsuitable for First-Line Chemotherapy: Updated Analysis (2012) (8)
- Primary pulmonary hypertension in a patient with HIV infection. (1998) (8)
- Cancer processes in immunodeficient populations: an introduction. (2001) (8)
- Establishing a KSHV 1 Cell Line ( BCP-1 ) From Peripheral Blood and Characterizing Its Growth in Nod / SCID Mice (1998) (8)
- Thymidine phosphorylase expression in Kaposi sarcoma. (1996) (7)
- Targeting EGFR in head and neck cancer: a decade of progress (2009) (7)
- Keynote Address V (2013) (7)
- Kaposi sarcoma herpesvirus : new perspectives (2007) (7)
- Accelerated cisplatin-based chemotherapy for advanced bladder cancer. (1995) (6)
- Kaposi's sarcoma--associated herpesvirus: a newly recognized pathogen. (1997) (6)
- Spontaneous fusion between splenocytes and myeloma cells induced by bacterial immunization. (1990) (6)
- Unraveling virus-induced lymphomagenesis. (2011) (6)
- HIV INFECTION AND NEOPLASIA. AUTHORS' REPLY (1996) (5)
- Is KSHV lytic growth induced by a methylation-sensitive switch? (2001) (5)
- African ancestry and innate immunity contribute to the incidence of multicentric Castleman’s disease in HIV-1/Kaposi’s sarcoma herpesvirus-coinfected individuals (2012) (5)
- Kaposi’s Sarcoma (1999) (5)
- Kaposis sarcoma-associated herpesvirus and Kaposis sarcoma in Africa. (1996) (5)
- Human Cell Culture (2002) (4)
- Abstract 162: DNA methylome in familial breast cancer identifies distinct profiles defined by mutation status (2010) (4)
- Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica - Response (1998) (4)
- New targets for cancer therapy: minireview reprints collection (2007) (4)
- Degradation of p 27 Kip cdk inhibitor triggered by Kaposi ’ s sarcoma virus cyclin – cdk 6 complex (2013) (4)
- AIDS associated tumors and HHV8 (1997) (3)
- HIV infection and neoplasia - Reply (1996) (3)
- Spontaneous hybridoma formation induced by immunization with Haemophilus paragallinarum: evidence for a lipopolysaccharide fusion inducer. (1992) (3)
- SEROLOGIC EVIDENCE FOR DIFFERENT ROUTES OF TRANSMISSION OF HHV-8 IN DIFFERENT POPULATIONS (1998) (3)
- KSHV infects monotypic (IgM lambda) but polyclonal naive B- cells in Castleman's disease and associated lymphoproliferative disorders (2001) (2)
- KSHV specific CTLs target Darwinian positively selected autologous epitopes within ORF-K1 (2003) (2)
- Kaposi’s Sarcoma and the Lymphatics (2009) (2)
- A PHASE II STUDY OF CONTINUOUS LOW DOSE THALIDOMIDE IN PATIENTS WITH RENAL CELL. MELANOMA, OVARIAN AND BREAST CANCER (1999) (1)
- Kaposi’s Sarcoma and Other HHV-8 Associated Tumors (2000) (1)
- Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors [see comments] (1997) (1)
- AIDS associated tumors and HHV8: S9 (1997) (1)
- Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma (2013) (1)
- Kaposi sarcoma, KSHV and lymphangiogenesis (2007) (1)
- ASSOCIATION BETWEEN HHV8, HIV, CANCER AND SELECTED RISK FACTORS IN SOUTH AFRICA (1998) (1)
- IDENTIFICATION OF HHV-8 SPECIFIC CYTOTOXIC T CELL RESPONSES (1999) (1)
- Methods employing cells derived from adult bone marrow (2003) (1)
- Treatment of good-risk, stage II, non-seminomatous testis cancer (1994) (1)
- HHV-8 SEROPREVALENCE AND DNA SEQUENCES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES AND NORMAL POPULATION FROM ITALY: 106 (1997) (0)
- Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors (2013) (0)
- New challenges to health: Gammaherpesviral infections and neoplasia in immunocompromised populations (2001) (0)
- Human herpesvirus-8 encoded chemokines (1999) (0)
- Cancer: The Evolutionary Legacy (2001) (0)
- SEROPREVALENCE OF KSHV OR HHV-8 IN CHILDREN FROM USA AND AFRICA (1999) (0)
- Primary pulmonary hypertension in a patient with HIV infection: case report (1998) (0)
- Extending the lineage potential of human mesenchymal stem cells (2006) (0)
- Several variants of HHV-8 are present in biopsies of HIV-negative “classical” and transplant-associated Kaposi's sarcoma (2007) (0)
- THE DISTRIBUTION OF HHV-8 LATENTLY INFECTED CELLS IN ALL STAGES OF KAPOSI'S SARCOMA (1999) (0)
- WHAT IS NEW IN MEDICAL TREATMENT (NEW AND FUTURE DRUGS AND CONCEPT) (2011) (0)
- Autologous K 1 Epitopes Target Darwinian Positively Selected Cytotoxic T Lymphocytes Recognize and Kaposi ' s Sarcoma-Associated Herpesvirus (2003) (0)
- A CASE CONTROL STUDY ON HIV ASSOCIATED KAPOSI'S SARCOMA: ANALYSIS OF HHV-8 SEROPREVALENCE AND SEXUAL BEHAVIOUR RISK FACTORS. (1999) (0)
- Abstract B28: Screening for kinase dependencies in HPV-associated cancer (2013) (0)
- HHV-8 infection in blood donors and patients with malignant and reactive lymphoproliferations from different regions of Italy (1998) (0)
- Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival (2014) (0)
- Targets for treatment: Lessons from aids-related malignancies (2002) (0)
- Kaposi Sarcoma Herpesvirus: Update (2005) (0)
- Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile (2003) (0)
- Kaposiʼs sarcoma-associated herpesvirus (KSHV) can he localized to the putative neoplastic cells of KS and is probably sexually transmitted (1996) (0)
- HIV-Associated Cancer (2003) (0)
- positive plasmablastic lymphoma - is linked to HHV-8 HHV-8 is associated with a plasmablastic variant of Castleman disease that (2013) (0)
- Kaposi's sarcoma associated Herpes virus human herpes virus 8: Have we really found the cause of Kaposi's sarcoma? (1996) (0)
- Etiology of AIDS related tumours (1995) (0)
- Current concepts in the management of sarcomas of the head and neck: A 10-year review of 25 patients to evaluate treatment modalities, survival and function (2007) (0)
- Adjuvant trials in bladder cancer: Scientific background, review, and new directions (1997) (0)
- How Does Measles Virus Kill Cancer Cells? Characterizing Oncolytic Measles Virus (OMV) Kinetics in a Mesenchymal Stromal Cell (MSC) Model of Cellular Transformation (2014) (0)
- AIDS and cancer (2001) (0)
- behavior during angiogenesis to modulate endothelial cell DLL4 The microRNA-30 family targets (2014) (0)
- HIV infection and neoplasia (1996) (0)
- Abstract 3169: APOBEC-mediated cytosine deamination is a prominent mutagenic mechanism in human papillomavirus-driven cancer (2014) (0)
- Early molecular regulation of adipogenesis in human mesenchymal stem cells (2005) (0)
- Characterization of monoclonal antibodies raised against the latent nuclear antigen (LNA) of human herpesvirus-8 (1999) (0)
- Abstract #LB-276: Intersection of genomic and epigenomic gene approaches identifies global disruption of the ECM pathway in colorectal cancer (2009) (0)
- A pilot study of gene expression analysis of recurrence in superficial bladder cancer (2003) (0)
- FOUND IN TRANSLATION Kidney cancer: The next decade (2018) (0)
- Kohn to Kaposi (2003) (0)
- Comprar Kaposi Sarcoma Herpesvirus: New Perspectives | Boshoff, C. | 9783540343431 | Springer (2007) (0)
- Putative role of Nrf2 as a tumor suppressor through inhibition of angiogenesis (2012) (0)
- Methylome Analysis of HPV-Associated Head and Neck Cancer (2011) (0)
- MP-04.06: Gene expression profile of urine sediment for the non-invasive diagnosis of bladder cancer (2007) (0)
- Human herpes virus 8 (HHV8) localisation in Castleman's disease raises important questions in relation to disease pathogenesis (1997) (0)
- 8-Specific Cytotoxic T-Cell Responses Identification of Human Herpesvirus (2013) (0)
- The biology of cancer (2006) (0)
- Current concepts in the management of sarcomas of the head and neck (2007) (0)
- Different cellular origin between primary effusion lymphoma with and without EBV infection. (2002) (0)
- The K15 protein of KSHV is latently expressed in all KSHV-related neoplasms and binds to HAX-1, a protein with anti-apoptotic function (2002) (0)
- Abstract 2976: KSHV-initiated Notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition (2012) (0)
- A successful year for the NIHR UCL Clinical Research Facility and Sarah Cannon Research (0)
- LIMD1, a tumor suppressor at 3p21.3, binds pRb and represses E2F-driven transcription (2004) (0)
- DNA Analysis Shows Huge Genetic Diversity in Tumours (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Christopher H. Boshoff?
Christopher H. Boshoff is affiliated with the following schools:
